BOK Financial’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
BOK Financial's IONS Position: Q3 2026 in Review
BOK Financial opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 74 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: BOK Financial previously reported a position in IONS as recently as Q1 2025.
BOK Financial first reported a position in IONS in Q1 2015 and has held it in 16 quarters since. The position peaked at $2.41M in Q2 2023. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- BOK Financial held 74 shares of Ionis Pharmaceuticals worth $3.3K as of Q3 2026.
- Ionis Pharmaceuticals was a new BOK Financial position in Q3 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of BOK Financial's portfolio in Q3 2026, its #1013 holding.
- BOK Financial first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 16 quarters since.
- BOK Financial's Ionis Pharmaceuticals position peaked at $2.41M in Q2 2023.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on BOK Financial's 13F filing for Q3 2026, filed 27 Oct 2026.